Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356323 · ClinicalTrials.gov registry record · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
A NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement, sponsored by Solventum US.
- Recruiting
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 2
- Study locations
NCT07356323: Recruiting NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement, sponsored by Solventum US.
NCT07356323 is a NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement that is actively recruiting participants, run by Solventum US. The registered enrollment target is 179 participants, roughly in line with the 188-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07356323, a NA study of Arthroplasty, Replacement, Knee and Arthroplasty Total Hip Replacement, is actively recruiting participants, sponsored by Solventum US.
- RECRUITING
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics. Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
Primary Outcome
Assessment of contamination at the surgical site during the operative procedure.
Conditions Studied
Interventions
- DEVICE 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)
Study Locations (2)
Indiana
- Indiana University Health (IU Health) - Fishers
Utah
- University of Utah Health - Department of Orthopedics - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07356323 shows while recruiting
NCT07356323 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 188-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target.
The record links to 2 conditions, with Arthroplasty, Replacement, Knee appearing as the primary indexed condition, and to 1 intervention - of which 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG) is the first listed.
NCT07356323 reports a single indexed study location in Indiana, Utah.
Frequently Asked Questions
What is clinical trial NCT07356323 about?
NCT07356323 is a clinical study titled "A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery". The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the...
What is the current status of trial NCT07356323?
This trial is currently recruiting. It is a NA study. The enrollment target is 179 participants. The study started on 2026-02-19. Estimated completion is 2026-05.
What conditions does trial NCT07356323 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee, Arthroplasty Total Hip Replacement.
What interventions are being tested in trial NCT07356323?
The interventions under investigation include: 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG) (DEVICE).
Who is sponsoring clinical trial NCT07356323?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07356323 being conducted?
This trial has 2 study locations across Indiana, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07356323's enrollment target sits among peer trials
179 4th of 12 higher than 9 of 12 other Arthroplasty, Replacement, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthroplasty, Replacement, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
TracPatch in Total Knee Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Music Therapy Versus Control for Total Knee Arthroplasty
COMPLETED · NA
-
Traditional vs Oral Fluid Management in Total Knee Arthroplasty
COMPLETED · NA
-
X-3 Polyethylene Survival Outcomes Study
COMPLETED · NA
-
Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI